| Ghofrani, H-A and Grimminger, F and Grunig, E and Huang, Y and Jansa, P and Jing, Z-C and Kilpatrick, D and Langleben, D and Rosenkranz, S and Menezes, F and Fritsch, A and Nikkho, S and Humbert, M, “Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: Data from the PATENT-2 open-label, randomised, long-term extension trial”, The Lancet Respiratory Medicine, 4 (5) pp. 361-371. ISSN 2213-2600 (2016) [Refereed Article] |
| Data Type | Value |
|---|
| Type of Research | Strategic Basic Research |
| Research Division | Biomedical and Clinical Sciences |
| Research Group | Cardiovascular medicine and haematology |
| Research Field | Cardiology (incl. cardiovascular diseases) |
| Research Objective Division | Health |
| Research Objective Group | Clinical health |
| Research Objective Field | Clinical health not elsewhere classified |
| Visit Item on eCite | http://ecite.utas.edu.au/117127 |
| Digital Object Identifier | doi:10.1016/S2213-2600(16)30019-4 |
| Scopus Source URL | View the full record on Scopus |
| Scopus Citing URL | View the list of citing articles on Scopus |
| Web of Science® Source URL | View the full record on Web of Science® |
| Web of Science® Citing URL | View the list of citing articles on Web of Science® |
| Web of Science® Related URL | View the list of related articles on Web of Science® |
| Number of Times Cited | 77 |
